Published in Biotech Business Week, October 9th, 2006
Moreover, POCT fits in with the way people envisage the delivery of future healthcare, one that promotes enhanced quality of care and encourages patients to be more involved in their own disease management. The report, titled "European Point of Care Testing Market," finds that the European POCT market earned revenues of US$754.4 million in 2005 and estimates this to reach US$1558.2 million in 2012.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.